Headlines about National Research (NASDAQ:NRCIB) have been trending somewhat positive on Friday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. National Research earned a media sentiment score of 0.04 on Accern’s scale. Accern also assigned news headlines about the business services provider an impact score of 45.3184557855572 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
National Research (NASDAQ:NRCIB) opened at $55.92 on Friday. The stock has a market cap of $1,365.85, a PE ratio of 78.58 and a beta of 0.07. National Research has a one year low of $38.76 and a one year high of $58.16.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 12th. Stockholders of record on Friday, December 29th will be paid a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 4.29%. The ex-dividend date of this dividend is Thursday, December 28th. National Research’s dividend payout ratio (DPR) is presently 480.00%.
National Research Company Profile
National Research Corporation provides analytics and insights for the patient and employee experience in serving the healthcare providers, payers, and other healthcare organizations in the United States and Canada. Its portfolio of subscription-based solutions offer information and analysis services in a range of elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.